| 2026-05-12 |
详情>>
内部人交易：
McRaven William H.股份增加7434.00股
|
| 2026-05-01 |
详情>>
股本变动：
变动后总股本38431.23万股
|
| 2026-05-01 |
详情>>
业绩披露：
2026年一季报每股收益-0.05美元,归母净利润-145.4万美元,同比去年增长-105.73%
|
| 2026-05-01 |
财报披露：
美东时间 2026-05-01 盘前发布财报
|
| 2026-04-21 |
股东大会：
将于2026-06-03召开股东大会
会议内容 ▼▲
- 1.To elect to the board of directors the 14 nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2027 (Item 1);
2.To elect to the Executive Committee the nine nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2027 (Item 2);
3.To consider and vote on a non-binding advisory resolution to approve the compensation paid to our named executive officers for our 2025 fiscal year (commonly known as “say-on-pay”) (Item 3);
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 (Item 4);
5.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|
| 2026-02-17 |
详情>>
业绩披露：
2025年年报每股收益0.89美元,归母净利润1.85亿美元,同比去年增长686.05%
|
| 2026-02-17 |
详情>>
业绩披露：
2023年年报每股收益0.89美元,归母净利润8009.00万美元,同比去年增长-13.35%
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.43美元,归母净利润1.07亿美元,同比去年增长923.27%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益0.10美元,归母净利润4033.40万美元,同比去年增长2515.69%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益0.08美元,归母净利润2539.30万美元,同比去年增长63.63%
|
| 2025-04-23 |
股东大会：
将于2025-06-05召开股东大会
会议内容 ▼▲
- 1.To elect to the board of directors the 13 nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2026 (Item 1);
2.To elect to the Executive Committee the nine nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2026 (Item 2);
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 (Item 3);
4.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-18 |
详情>>
业绩披露：
2024年年报每股收益0.00美元,归母净利润2348.30万美元,同比去年增长-70.68%
|
| 2025-02-18 |
详情>>
业绩披露：
2022年年报每股收益1.10美元,归母净利润9242.60万美元,同比去年增长-95.44%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.04美元,归母净利润1050.30万美元,同比去年增长-84.3%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.08美元,归母净利润154.20万美元,同比去年增长-97.05%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.09美元,归母净利润1551.90万美元,同比去年增长-38.06%
|
| 2024-04-24 |
股东大会：
将于2024-06-05召开股东大会
会议内容 ▼▲
- 1.To elect to the board of directors the 17 nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2025 (Item 1);
2.To elect to the Executive Committee the 11 nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2025 (Item 2);
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 (Item 3);
4.To approve an amendment to the Company’s certificate of incorporation providing for officer exculpation under Delaware law (Item 4);
5.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|
| 2023-04-25 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect to the board of directors the fourteen nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2024 (Item 1);
2.To elect to the Executive Committee the eight nominees named in the accompanying proxy statement, in each case for a one-year term expiring at the annual meeting of stockholders of TPG to be held in 2024 (Item 2);
3.To consider and vote on a non-binding advisory resolution to approve the compensation paid to our named executive officers for our 2022 fiscal year (commonly known as “say-on-pay”) (Item 3);
4.To consider and vote on a non-binding advisory determination of the frequency of future advisory votes on the compensation paid to our named executive officers (commonly known as “say-on-frequency”) (Item 4);
5.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023 (Item 5);
6.To adopt the amended and restated certificate of incorporation in the form attached as Appendix 2 to the accompanying proxy statement to provide our board of directors with the powers currently reserved solely for the Executive Committee (Item 6);
7.To transact any other business that may be properly presented at the Annual Meeting or any adjournment or postponement thereof.
|